Zobrazeno 1 - 9
of 9
pro vyhledávání: '"N. Oukhouya Daoud"'
Publikováno v:
Revue du Rhumatisme. 89:A63
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
François Pattou, M. Desseigne, Estelle Aubry, A. Maghroudi, I. Gueorguieva, Hélène Verkindt, N. Oukhouya Daoud
Publikováno v:
Les Obésités
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7017687e42c67f81244bd9e6f9c1c6ce
https://doi.org/10.1016/b978-2-294-76753-1.00109-0
https://doi.org/10.1016/b978-2-294-76753-1.00109-0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Nutrition Clinique et Métabolisme. 32:261
Introduction et but de l’etude La limitation de l’activite physique, liee ou non a des comorbidites, conduit au deconditionnement c’est-a-dire une perte des capacites d’adaptation cardiovasculaire et musculaire a l’effort. L’epreuve d’e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Raverdy V; Translational Research for Diabetes UMR 1190, University of Lille, Inserm, Institut Pasteur Lille, CHU Lille, Lille, France.; Department of General and Endocrine Surgery, Centre Hospitalier et Universitaire de Lille, Lille, France., Tavaglione F; Operative Unit of Clinical Medicine and Hepatology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Research Unit of Clinical Medicine and Hepatology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy., Chatelain E; US 41 - UAR 2014 - PLBS Bilille, University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, F-59000, Lille, France., Lassailly G; Department of Hepato-Gastroenterology CHU Lille, University of Lille, Inserm INFINITE-U1286, Lille, France., De Vincentis A; Operative Unit of Internal Medicine, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Research Unit of Internal Medicine, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy., Vespasiani-Gentilucci U; Operative Unit of Clinical Medicine and Hepatology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Research Unit of Clinical Medicine and Hepatology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy., Qadri SF; Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Minerva Foundation Institute for Medical Research, Helsinki, Finland., Caiazzo R; Translational Research for Diabetes UMR 1190, University of Lille, Inserm, Institut Pasteur Lille, CHU Lille, Lille, France.; Department of General and Endocrine Surgery, Centre Hospitalier et Universitaire de Lille, Lille, France., Verkindt H; Translational Research for Diabetes UMR 1190, University of Lille, Inserm, Institut Pasteur Lille, CHU Lille, Lille, France.; Department of General and Endocrine Surgery, Centre Hospitalier et Universitaire de Lille, Lille, France., Saponaro C; Translational Research for Diabetes UMR 1190, University of Lille, Inserm, Institut Pasteur Lille, CHU Lille, Lille, France., Kerr-Conte J; Translational Research for Diabetes UMR 1190, University of Lille, Inserm, Institut Pasteur Lille, CHU Lille, Lille, France., Baud G; Translational Research for Diabetes UMR 1190, University of Lille, Inserm, Institut Pasteur Lille, CHU Lille, Lille, France.; Department of General and Endocrine Surgery, Centre Hospitalier et Universitaire de Lille, Lille, France., Marciniak C; Translational Research for Diabetes UMR 1190, University of Lille, Inserm, Institut Pasteur Lille, CHU Lille, Lille, France.; Department of General and Endocrine Surgery, Centre Hospitalier et Universitaire de Lille, Lille, France., Chetboun M; Translational Research for Diabetes UMR 1190, University of Lille, Inserm, Institut Pasteur Lille, CHU Lille, Lille, France.; Department of General and Endocrine Surgery, Centre Hospitalier et Universitaire de Lille, Lille, France., Oukhouya-Daoud N; Translational Research for Diabetes UMR 1190, University of Lille, Inserm, Institut Pasteur Lille, CHU Lille, Lille, France.; Department of General and Endocrine Surgery, Centre Hospitalier et Universitaire de Lille, Lille, France., Blanck S; ULR 2694 METRICS: Évaluation des technologies de santé et des pratiques médicales, University of Lille, CHU Lille, F-59000, Lille, France., Vandel J; US 41 - UAR 2014 - PLBS Bilille, University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, F-59000, Lille, France., Olsson L; Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden., Chakaroun R; Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden., Gnemmi V; Cancer Heterogeneity Plasticity and Resistance to Therapies, CANTHER-UMR9020-U1277 - CNRS, Inserm, CHU Lille, University of Lille, Lille, France.; Department of Pathology, CHU Lille, University of Lille, Lille, France., Leteurtre E; Cancer Heterogeneity Plasticity and Resistance to Therapies, CANTHER-UMR9020-U1277 - CNRS, Inserm, CHU Lille, University of Lille, Lille, France.; Department of Pathology, CHU Lille, University of Lille, Lille, France., Lefebvre P; Nuclear Receptors, Metabolic and Cardiovascular Diseases - U1011, University of Lille, Inserm, CHU Lille, Institut Pasteur Lille, Lille, France., Haas JT; Nuclear Receptors, Metabolic and Cardiovascular Diseases - U1011, University of Lille, Inserm, CHU Lille, Institut Pasteur Lille, Lille, France., Yki-Järvinen H; Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Minerva Foundation Institute for Medical Research, Helsinki, Finland., Francque S; Department of Gastroenterology Hepatology, Antwerp University Hospital, Edegem, Belgium.; InflaMed Centre of Excellence, Laboratory for Experimental Medicine and Paediatrics, Translational Sciences in Inflammation and Immunology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium., Staels B; Nuclear Receptors, Metabolic and Cardiovascular Diseases - U1011, University of Lille, Inserm, CHU Lille, Institut Pasteur Lille, Lille, France., Le Roux CW; Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland., Tremaroli V; Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden., Mathurin P; Department of Hepato-Gastroenterology CHU Lille, University of Lille, Inserm INFINITE-U1286, Lille, France., Marot G; ULR 2694 METRICS: Évaluation des technologies de santé et des pratiques médicales, University of Lille, CHU Lille, F-59000, Lille, France.; MODAL: Models for Data Analysis and Learning, Inria, F-59000, Lille, France., Romeo S; Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. stefano.romeo@wlab.gu.se.; Clinical Nutrition Unit, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy. stefano.romeo@wlab.gu.se.; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden. stefano.romeo@wlab.gu.se.; Department of Medicine Huddinge (H7), Karolinska Institutet and University Hospital, Stockholm, Sweden. stefano.romeo@wlab.gu.se.; Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg University, Gothenburg, Sweden. stefano.romeo@wlab.gu.se., Pattou F; Translational Research for Diabetes UMR 1190, University of Lille, Inserm, Institut Pasteur Lille, CHU Lille, Lille, France. francois.pattou@univ-lille.fr.; Department of General and Endocrine Surgery, Centre Hospitalier et Universitaire de Lille, Lille, France. francois.pattou@univ-lille.fr.
Publikováno v:
Nature medicine [Nat Med] 2024 Dec; Vol. 30 (12), pp. 3624-3633. Date of Electronic Publication: 2024 Dec 09.
Autor:
Peschard S; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France., Raverdy V; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France.; Department of General and Endocrine Surgery, CHU Lille, Lille, France., Bauvin P; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France., Goutchtat R; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France., Touche V; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France., Derudas B; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France., Gheeraert C; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France., Dubois-Chevalier J; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France., Caiazzo R; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France.; Department of General and Endocrine Surgery, CHU Lille, Lille, France., Baud G; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France.; Department of General and Endocrine Surgery, CHU Lille, Lille, France., Marciniak C; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France.; Department of General and Endocrine Surgery, CHU Lille, Lille, France., Verkindt H; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France.; Department of General and Endocrine Surgery, CHU Lille, Lille, France., Oukhouya Daoud N; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France.; Department of General and Endocrine Surgery, CHU Lille, Lille, France., Le Roux CW; Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland., Lefebvre P; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France., Staels B; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France., Lestavel S; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1011 Nuclear Receptors, Metabolic and Cardiovascular Diseases, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France., Pattou F; European Genomic Institute for Diabetes, University Lille, Lille, France.; U1190 Translational Research on Diabetes, Institut Pasteur de Lille, CHU Lille, INSERM, University Lille, Lille, France.; Department of General and Endocrine Surgery, CHU Lille, Lille, France.
Publikováno v:
Diabetes [Diabetes] 2024 Jun 01; Vol. 73 (6), pp. 983-992.